German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study evaluates the efficacy and tolerability of a dose-reduced chemotherapy for the
treatment of elderly patients with acute lymphoblastic leukemia. In patients with expression
of CD20 on leukemic cells the efficacy and tolerability of additional application of
Rituximab together with chemotherapy is evaluated.